BCSF Stock Analysis: Bain Capital Specialty | NYSE
Asset Management | NYSE, USA | Market Cap: 782m USD | 12M Return: -9.3% | US05684B1070 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.02M
EPS Trend: -85.6%
Qual. Beats: 1
Rev. Trend: -94.3%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 7.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bain Capital Specialty Finance, Inc. (BCSF) is a publicly traded business development company (BDC) that provides direct loans to U.S. middle-market companies. It focuses primarily on senior-secured credit instruments, including first lien, stretch senior, unitranche, second lien, and mezzanine debt, along with selective junior securities and secondary debt purchases. The company generally targets borrowers with EBITDA between $10 million and $150 million.
As a BDC, BCSF operates under a regulatory framework that requires it to distribute the majority of its taxable earnings to shareholders, making dividend yield a key component of its investment profile. The firm benefits from Bain Capitals broader credit platform, which provides sourcing, underwriting, and portfolio management capabilities to middle-market lenders, a market segment that often has limited access to traditional bank financing.
- Net interest margin expands as base rates remain elevated
- Middle-market credit quality holds with low non-accrual rate
- Private credit competition pressures new deal spreads
| Net Income: 78.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.19 > 1.0 |
| NWC/Revenue: -187.1% < 20% (prev 39.86%; Δ -227.0% < -1%) |
| CFO/TA 0.03 > 3% & CFO 74.6m > Net Income 78.5m |
| Net Debt (1.39b) to EBITDA (114.5m): 12.10 < 3 |
| Current Ratio: 0.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.9m) vs 12m ago 0.00% < -2% |
| Gross Margin: 66.56% > 18% (prev 61.15%; Δ 5.40% > 0.5%) |
| Asset Turnover: 7.14% > 50% (prev 7.39%; Δ -0.25% > 0%) |
| Interest Coverage Ratio: 1.35 > 6 (EBIT TTM 109.3m / Interest Expense TTM 80.8m) |
| A: -0.14 (Total Current Assets 239.7m - Total Current Liabilities 600.0m) / Total Assets 2.62b |
| B: -0.03 (Retained Earnings -80.8m / Total Assets 2.62b) |
| C: 0.04 (EBIT TTM 109.3m / Avg Total Assets 2.70b) |
| D: 0.70 (Book Value of Equity 1.08b / Total Liabilities 1.54b) |
| Altman-Z'' = 0.01 = B |
As of August 23, 2026, the stock is trading at USD 12.06 with a total of 303,071 shares traded. Over the past week, the price has changed by -3.90%, over one month by -5.93%, over three months by -6.27% and over the past year by -9.33%.
Current recommended Stop Loss: 11.50 (which is 4.6% or 1.8 ATR below the current price).
Bain Capital Specialty has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold BCSF.
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 13.3 | 10.5% |
P/E Trailing = 12.6947
P/E Forward = 10.1112
P/S = 2.9662
P/B = 0.7241
P/EG = 1.0474
Revenue TTM = 192.6m USD
EBIT TTM = 109.3m USD
EBITDA TTM = 114.5m USD
Long Term Debt = unknown (none)
Short Term Debt = 600.0m USD (from shortTermDebt, last fiscal year)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.39b USD (calculated: Debt 1.50b - CCE 115.7m)
Enterprise Value = 2.17b USD (782.3m + Debt 1.50b - CCE 115.7m)
Interest Coverage Ratio = 1.35 (Ebit TTM 109.3m / Interest Expense TTM 80.8m)
EV/FCF = 29.08x (Enterprise Value 2.17b / FCF TTM 74.6m)
FCF Yield = 3.44% (FCF TTM 74.6m / Enterprise Value 2.17b)
FCF Margin = 38.71% (FCF TTM 74.6m / Revenue TTM 192.6m)
Net Margin = 40.75% (Net Income TTM 78.5m / Revenue TTM 192.6m)
Gross Margin = 66.56% ((Revenue TTM 192.6m - Cost of Revenue TTM 64.4m) / Revenue TTM)
Gross Margin QoQ = 78.38% (prev 72.55%)
Tobins Q-Ratio = 0.83 (Enterprise Value 2.17b / Total Assets 2.62b)
Interest Expense / Debt = 5.38% (Interest Expense 80.8m / Debt 1.50b)
Taxrate = 4.82% (3.24m / 67.2m)
NOPAT = 104.0m (EBIT 109.3m * (1 - 4.82%))
Current Ratio = 0.40 (Total Current Assets 239.7m / Total Current Liabilities 600.0m)
Debt / Equity = 1.39 (Debt 1.50b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 12.10 (Net Debt 1.39b / EBITDA 114.5m)
Debt / FCF = 18.58 (Net Debt 1.39b / FCF TTM 74.6m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.91% (Net Income 78.5m / Total Assets 2.62b)
RoE = 7.10% (Net Income TTM 78.5m / Total Stockholder Equity 1.10b)
RoCE = 5.41% (EBIT 109.3m / Capital Employed (Total Assets 2.62b - Current Liab 600.0m))
RoIC = 3.98% (NOPAT 104.0m / Invested Capital 2.61b)
WACC = 6.15% (E(782.3m)/V(2.28b) * Re(8.11%) + D(1.50b)/V(2.28b) * Rd(5.38%) * (1-Tc(0.05)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.95 | Cagr: 0.21%
[DCF] Terminal Value 73.10% ; FCFF base≈89.5m ; Y1≈78.5m ; Y5≈63.4m
[DCF] Fair Price = N/A (negative equity: EV 1.02b - Net Debt 1.39b = -367.5m; debt exceeds intrinsic value)
EPS Correlation: -85.63 | EPS CAGR: -6.31% | SUE: 1.01 | # QB: 1
Revenue Correlation: -94.28 | Revenue CAGR: -6.29% | SUE: -0.93 | # QB: -1
EPS current Quarter (2026-09-30): EPS=0.43 | Chg30d=-0.76% | Revisions=+40% | Analysts=2
EPS current Year (2026-12-31): EPS=1.67 | Chg30d=-0.79% | Revisions=-25% | GrowthEPS=-11.0% | GrowthRev=-7.8%
EPS next Year (2027-12-31): EPS=1.41 | Chg30d=-4.72% | Revisions=-25% | GrowthEPS=-15.5% | GrowthRev=-6.3%
[Analyst] Revisions Ratio: +0% (up=2, down=2)